News FocusBhutan

Improbable Partners Aim to Bring Biotechnology to a Himalayan Kingdom

See allHide authors and affiliations

Science  19 Feb 2010:
Vol. 327, Issue 5968, pp. 940-941
DOI: 10.1126/science.327.5968.940

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

British mycologist Nigel Hywel-Jones is serving as an adviser to Bhutan Pharmaceuticals Private Ltd., a company founded by local entrepreneur Wangdi Jamyang. Besides prospecting for fungi that attack insects and culturing isolates that may have medicinal value, Hywel-Jones is crafting a business model for biotech in the kingdom. There is no dearth of raw materials. Bhutan's highlands are a prime habitat for at least one prized commodity: an insect fungus, Cordyceps sinensis, that fetches outrageous prices as a Chinese medicine. Hywel-Jones believes that Bhutan, a biodiversity hot spot, may harbor a wealth of novel compounds for Western medicine, too. But the duo insists that they are not embarking on a biological Gold Rush. Wangdi emphasizes that their activities will be guided by a Buddhist reverence for the environment enshrined in Bhutan's 2008 constitution, which calls for preserving 65% of the country as forest.